Inventor
LAZAR GREGORY ALAN
US72 patents
⚠️ This page may combine multiple inventors who share the name “LAZAR GREGORY ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
18 patentsUS8367805B2Feb 5, 2013
Fc variants with altered binding to FcRn
XENCOR INC210 citations99
US8039592B2Oct 18, 2011
Optimized Fc variants and methods for their generation
XENCOR INC86 citations99
US7662925B2Feb 16, 2010
Optimized Fc variants and methods for their generation
XENCOR INC349 citations99
US7657380B2Feb 2, 2010
Methods of generating variant antibodies with increased host string content
XENCOR INC169 citations99
US7317091B2Jan 8, 2008
Optimized Fc variants
XENCOR INC872 citations99
US7276585B2Oct 2, 2007
Immunoglobulin variants outside the Fc region
XENCOR INC197 citations99
US8383109B2Feb 26, 2013
Optimized Fc variants and methods for their generation
XENCOR INC40 citations98
US10336818B2Jul 2, 2019
Fc variants with altered binding to FcRn
XENCOR INC47 citations97
US9803023B2Oct 31, 2017
Fc variants with altered binding to FcRn
XENCOR INC62 citations97
US8802823B2Aug 12, 2014
Optimized Fc variants
XENCOR INC24 citations96
US10184000B2Jan 22, 2019
Optimized Fc variants and methods for their generation
XENCOR INC20 citations94
US9051373B2Jun 9, 2015
Optimized Fc variants
XENCOR INC40 citations94
US10183999B2Jan 22, 2019
Optimized Fc variants and methods for their generation
XENCOR INC10 citations92
US9353187B2May 31, 2016
Optimized FC variants and methods for their generation
XENCOR INC21 citations92
US8858937B2Oct 14, 2014
Optimized Fc variants and methods for their generation
XENCOR INC20 citations92
US9902773B2Feb 27, 2018
Methods and compositions for inhibiting CD32b expressing cells
XENCOR INC4 citations84
US8735547B2May 27, 2014
Optimized Fc Variants
XENCOR INC5 citations84
US7930107B2Apr 19, 2011
Methods of generating variant proteins with increased host string content
XENCOR INC13 citations84
LAZAR GREGORY ALAN
13 patentsUS8388955B2Mar 5, 2013
Fc variants
LAZAR GREGORY ALAN104 citations99
US8188231B2May 29, 2012
Optimized FC variants
LAZAR GREGORY ALAN188 citations99
US8937158B2Jan 20, 2015
Fc variants with increased affinity for FcγRIIc
LAZAR GREGORY ALAN56 citations98
US8735545B2May 27, 2014
Fc variants having increased affinity for fcyrllc
LAZAR GREGORY ALAN59 citations98
US8546543B2Oct 1, 2013
Fc variants that extend antibody half-life
LAZAR GREGORY ALAN60 citations98
US8124731B2Feb 28, 2012
Optimized Fc variants and methods for their generation
LAZAR GREGORY ALAN55 citations98
US8093359B2Jan 10, 2012
Optimized Fc variants and methods for their generation
LAZAR GREGORY ALAN58 citations98
US8093357B2Jan 10, 2012
Optimized Fc variants and methods for their generation
LAZAR GREGORY ALAN51 citations98
US8399618B2Mar 19, 2013
Immunoglobulin insertions, deletions, and substitutions
LAZAR GREGORY ALAN24 citations93
US8753629B2Jun 17, 2014
Optimized Fc variants
LAZAR GREGORY ALAN29 citations92
US8734791B2May 27, 2014
Optimized fc variants and methods for their generation
LAZAR GREGORY ALAN19 citations92
US9102739B2Aug 11, 2015
Anti-glypican-3 antibody
LAZAR GREGORY ALAN17 citations91
US8753628B2Jun 17, 2014
Optimized Fc variants
LAZAR GREGORY ALAN5 citations84
CHAMBERLAIN AARON KEITH
9 patentsUS8394925B2Mar 12, 2013
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH63 citations99
US8088376B2Jan 3, 2012
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH191 citations99
US8883973B2Nov 11, 2014
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH57 citations98
US8802820B2Aug 12, 2014
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH83 citations96
US8338574B2Dec 25, 2012
FC variants with altered binding to FCRN
CHAMBERLAIN AARON KEITH32 citations96
US8324351B2Dec 4, 2012
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH30 citations96
US8318907B2Nov 27, 2012
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH27 citations96
US9200079B2Dec 1, 2015
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH28 citations92
US8852586B2Oct 7, 2014
Fc variants with altered binding to FcRn
CHAMBERLAIN AARON KEITH12 citations92
CHU SEUNG YUP
4 patentsUS8063187B2Nov 22, 2011
Methods and compositions for inhibiting CD32B expressing cells
CHU SEUNG YUP130 citations98
US9394366B2Jul 19, 2016
Methods and compositions for inhibiting CD32B expressing cells
CHU SEUNG YUP16 citations92
US9260523B2Feb 16, 2016
Methods and compositions for inhibiting CD32b expressing cells
CHU SEUNG YUP9 citations92
US9079960B2Jul 14, 2015
Methods and compositions for inhibiting CD32B expressing cells
CHU SEUNG YUP12 citations92
BERNETT MATTHEW J
2 patentsLILLY CO ELI
2 patentsDAHIYAT BASSIL I
1 patentDESJARLAIS JOHN R
1 patentShowing the top 50 of 72 patents by PatentIndex Score.